Inhibition of experimental tobacco carcinogen induced head and neck carcinogenesis

Oral Oncology

Volumn 40, Issue 6, 2004, Pages 611-623

  Schwartz, Joel ^a   Baker, Vikki ^a   Larios, Eric ^a   Desai, Dhimant ^a   Amin, Shantu ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

Dibenzo a,l pyrene; Head and neck carcinoma; Tobacco carcinogen; Vitamin E acid succinate

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 HYDROXYDEOXYGUANOSINE GLYCOSYLASE; ALPHA TOCOPHEROL SUCCINATE; BROXURIDINE; CARCINOGEN; DIBENZO[A,L]PYRENE; EXODEOXYRIBONUCLEASE III; FORMAMIDOPYRIMIDINE; ISOENZYME; PROPIDIUM IODIDE; PROTEIN P53; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANEUPLOIDY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; COMET ASSAY; CONTROLLED STUDY; CYTOLOGY; DNA DAMAGE; DNA REPAIR; DYSPLASIA; FEMALE; FLOW CYTOMETRY; HEAD AND NECK CANCER; KERATINOCYTE; MITOSIS INHIBITION; NICK END LABELING; NONHUMAN; NUCLEOSOME; OXIDATIVE STRESS; PRIORITY JOURNAL; SYRIAN HAMSTER; TOBACCO;

ANEUPLOIDY; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOPYRENES; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; CRICETINAE; DISEASE MODELS, ANIMAL; DNA REPAIR; DNA, NEOPLASM; HYDROLYSIS; KERATINOCYTES; MESOCRICETUS; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MOUTH NEOPLASMS; VITAMIN E;

EID: 1842529556     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2003.12.012     Document Type: Article

References (41)

1. Centers for Disease Control and Prevention (CDC). Cigarette smoking-attributable morbidity-United States, 2000. MMWR Morb Mortal Wkly Resp 2003;52:842-4.
2. Schwartz J.L. Hamster oral cancer model. Teicher B. Models in Tumor Biology. 2000;Humana Press, New York. Chapter 38.
3. Salley J.J. Experimental carcinogenesis in the cheek pouch of the Syrian hamster. J. Dent. Res. 33:1954;253-262.
4. Schwartz J.L., Gu X., Kittles R.A., Baptiste A., Shklar G. Experimental oral carcinoma of the tongue and buccal mucosa: possible biologic markers linked to cancers at two anatomic sites. Eur. J. Cancer Oral. Oncol. 36:2000;225-235.
5. Rao A.R. Modifying influences of betel quid ingredients on B[a]P-induced carcinogenesis in the buccal pouch of hamster. Int. J. Cancer. 33:1984;581-586.
6. Prahalad A.K., Ross J.A., Nelson G.B., Roop B.C., King L.C., Nesnow S.et al. Dibenzo[a,l]pyrene-induced DNA adduction tumorigenicity, and Ki-ras oncogene mutations in strains A/J mouse lung. Carcinogenesis. 18:1997;1955-1963.
7. Cavalieri E.L., Higginbothan S., RamaKrishna N.V., Devanesan P.D., Todorovic R., Rogan E.G.et al. Comparative dose-response tumorigenicity studies of dibenzo[alpha,l]pyrene versus 7,12 diemethylbenz[alpha]anthracene, benzo[alpha]pyrene and two dibenzo[alpha,l]pyrene dihdrodiols in mouse skin and rat mammary gland. Carcinogenesis. 12:1991;1939-1944.
8. Higginbotham S., RamaKrishna N.V., Johansson S.L., Rogan E.G., Cavalieri E.L. Tumor-initiating activity and carcinogeneicity of dibenzo[a,l]pyrene versus 7,12 dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin. Carcinogenesis. 14:1993;875-878.
9. La Voie E.J., He Z.M., Meegalla R.L., Weyand E.H. Exceptional tumor-initiating activity of 4-fluorobenzo[j]-fluoranthene on mouse skin: comparison with benz[j]-fluoranthene, 10-fluoranthene, benzo[a]pyrene, dibenzo[a,l]pyrene and 7,12 dimethylbenz[a]anthracene. Cancer Lett. 70:1993;7-14.
10. Schwartz J.L. Molecular and biochemical control of tumor growth following treatment with carotenoids or tocopherols. Prasad K., Santamaria R.M., Williams R.M. Nutrition and Cancer Prevention and Treatments. 1995;287-316 Humana Press, Totowa, NJ.
11. Schwartz J.L., Shklar G., Trickler D. p53 in the anticancer mechanism of vitamin E. Eur. J. Cancer Oral. Oncol. 29B:1993;313-318.
12. Shklar G., Schwartz J.L. Vitamin E inhibits experimental carcinogenesis and tumour angiogenesis. Oral Oncol, Eur. J. Cancer. 32B:1996;114-119.
13. Garewal H.S. Beta-carotene and vitamin E in oral cancer prevention. J. Cell. Biochem. Suppl. 17:1993;262-269.
14. Brenner S.C., Winn R.J., Lippman S.M.et al. Regression of oral leukoplakia with alpha tocopherol: a community clinical oncology program, Chemopreventative study. J. Natl. Cancer Inst. 85:1993;44-48.
15. Shklar G., Schwartz J.L. Tumor necrosis factor in experimental cancer: regression with alpha tocopherol, beta carotene, and algae extract. Eur. J. Cancer Clin. Oncol. 24:1988;839-850.
16. Schwartz J.L., Tanaka V., Khandekar V., Herman T.S., Teicher B. Beta carotene and/or vitamin E as modulators of alkylating agents in SCC-25 human squamous carcinoma cells. Cancer Chemoth. Pharm. 29:1991;207-213.
17. Sigounas G., Anagnostou A., Steiner M. Dl-alpha-tocopherol induces apoptosis in erythroleukemia prostate and breast cells. Nutr. Cancer. 28:1997;30-35.
18. Schwartz J.L., Antoniades D.Z., Zhao S. Molecular and biochemical reprogramming of carcinogenesis thru the activity of antioxidants and prooxidants. NY Acad. Sci. 686:1992;262-279.
19. Shklar G., Schwartz J.L. Effects of vitamin E on oral carcinogenesis and oral cancer. Pacher L., Fuchs J. 1993;497-511 Marcel Dekker, New York.
20. Kline K., Yu W., Sanders B.G. Vitamin E mechanisms of action as tumor cell growth inhibitors. J. Nutr. 131:2001;143-163S.
21. Papas A., Vos E. Vitamin E: Cancer and apoptosis. Am. J. Clin. Nutr. 73:2001;1113-1114.
22. Zhang J.G., Fariss M.W. Thenoyltrifluoracetone, a potent inhibitor of carboxylesterase activity. Biochem. Pharmacol. 63:2002;751-754.
23. Schwartz J.L., Muscat J.E., Baker V., Larios E., Stepenson G.D., Guo W. et al. Oral cytology assessment by flow cytomery of DNA adducts, aneuploidy, proliferation, and apoptosis shows differences between smokers and non-smokers. Oral Oncol. 39:2003;842-854.
24. Leonard S.W., Terasawa Y., Farese R.V. Jr., Traber M.G. Incorporation of deuterated RRR-or all-rac-alpha-tocopherol in plasma and tissues of alpha-tocopherol transfer protein - null mice. Am. J. Clin. Nutr. 75:2002;555-560.
25. Kaempf-Rotzoll D.E., Traber M.G., Arai H. Vitamin E and transfer proteins. Curr. Opin. Lipidol. 14:2003;249-254.
26. Azzi A., Ricciarelli R., Zingg J.M. Non-antioxidant molecular functions of alpha-tocopherol (vitamin E). FEBS Lett. 519:2002;8-10.
27. Kalikin L.M., Bugeaud E.M., Palmbos P.L., Lyons R.H. Jr., Petty E.M. Genomic characterization of human SEC14L1 splice variants within a17q25 candidate suppressor gene region and identification of an unrelated embedded expressed sequence. Mamm. Genome. 12:2001;925-929.
28. Swanson H.I. DNA binding and protein interactions of the AHR/ARNT heterodimer that facilitate gene activation. Chem. Biol. Interact. 141:2002;63-76.
29. Sogawa K., Nakano R., Kobayashi A., Kiluchi Y., Ohe N., Matsushita N.et al. Possible function of Ah receptor nuclear translocator (Arnt) homodimer in transcriptional regulation. Proc. Natl. Acad. Sci. USA. 92:1995;136-1940.
30. Rushmore T.H., Kong T.A.N. Pharacogenomics, regulation and signaling pathways of Phase I and II drug metabolizing enzymes. Cur. Drug Metabol. 3:2002;481-490.
31. Xu G., Zhang W., Ma M.K., McLeod H.L. Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan. Clin. Cancer Res. 8:2002;2605-2611.
32. Robichova S., Slamenova D. Study of N-nitrosomorpholine-induced DNA strand breaks in Caco-2 cells by the classical and modified comet assay: influence of vitamins E and C. Nutr. Cancer. 39:2001;267-272.
33. Brigelius-Flohe R. Vitamin E and drug metabolism. Biochem. Biophys. Res. Commun. 305:2003;737-740.
34. Packer L., Fuchs J. Vitamin E in health and disease. 1993;Marcel Dekker, New York.
35. Patel V., Jakus J., Harris C.M., Ensley J.F., Robbins K.C., Yeudall W.A. Altered expression and activity of Gl/S cyclins and cyclin-dependent kinase characterize squamous cell carcinoma of the head and neck. Int. J. Cancer. 73:1997;551-555.
36. Sen S. Aneuploidy and cancer. Curr. Opin. Oncol. 12:2000;82-88.
37. Brinkley B.R. Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends. Cell Biol. 11:2001;18-21.
38. Duesberg P., Rasnick D. Aneuploidy the somatic mutation that makes cancer a species of its own. Cell Motil. Cytoskel. 47:2000;81-107.
39. Duesberg P., Li R., Rasnick D., Rausch C., Willer A.et al. Aneuploidy precedes and segregates with chemical carcinogenesis. Cancer Genet. Cytogenet. 119:2000;83-93.
40. Mao L., El-Naggar A.K., Papdimitrakopoulou V., Shin D.M., Shin H.C., Zhou X.et al. Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. J. Natl. Cancer Inst. 90:1998;1545-1551.
41. Lykkesfedt J., Christen S., Wallock L.M., Chang H.H., Jacob R.A., Ames B.N. Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes. Am. J. Clin. Nutr. 71:2000;530-536.